1050.4000 9.40 (0.90%)
NSE Aug 22, 2025 15:31 PM
Volume: 1.9M
 

HDFC Securities
Aurobindo Pharma Ltd Q2FY19 results Comment Revenue grew by 11.61% to Rs. 4667.12 Cr in Q2FY19 when compared to the previous quarter. Also, it increased by 7.19% when compared with Q2FY18.
Aurobindo Pharma Ltd. has an average target of 1403.50 from 10 brokers.
More from Aurobindo Pharma Ltd.
Recommended